Supplemental Methods and Figure S1 from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R. Sundaresan,Chu-Xia Deng,Mahesh P. Gupta,Yu-Ying He

DOI: https://doi.org/10.1158/0008-5472.22404237

2023-01-01

Abstract:Supplemental Methods and Supplemental Figure S1: SIRT6 has no effect on UVB-induced DNA damage repair and checkpoint activation

What problem does this paper attempt to address?

Data from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R. Sundaresan,Chu-Xia Deng,Mahesh P. Gupta,Yu-Ying He

DOI: https://doi.org/10.1158/0008-5472.c.6506559

2023-01-01

Abstract:AbstractSIRT6 is a SIR2 family member that regulates multiple molecular pathways involved in metabolism, genomic stability, and aging. It has been proposed previously that SIRT6 is a tumor suppressor in cancer. Here, we challenge this concept by presenting evidence that skin-specific deletion of SIRT6 in the mouse inhibits skin tumorigenesis. SIRT6 promoted expression of COX-2 by repressing AMPK signaling, thereby increasing cell proliferation and survival in the skin epidermis. SIRT6 expression in skin keratinocytes was increased by exposure to UVB light through activation of the AKT pathway. Clinically, we found that SIRT6 was upregulated in human skin squamous cell carcinoma. Taken together, our results provide evidence that SIRT6 functions as an oncogene in the epidermis and suggest greater complexity to its role in epithelial carcinogenesis. Cancer Res; 74(20); 5925–33. ©2014 AACR.
Tumor and Stem Cell Biology SIRT 6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Mei Ming,Weinong Han,Baozhong Zhao,Nagalingam R. Sundaresan,Chu-Xia Deng,Mahesh P. Gupta,Yu-Ying He

2014-01-01

Abstract:SIRT6 is a SIR2 family member that regulates multiple molecular pathways involved in metabolism, genomic stability, and aging. It has been proposedpreviously that SIRT6 is a tumor suppressor in cancer. Here, we challenge this concept by presenting evidence that skin-specific deletion of SIRT6 in themouse inhibits skin tumorigenesis. SIRT6 promoted expression of COX-2 by repressing AMPK signaling, thereby increasing cell proliferation and survival in the skin epidermis. SIRT6 expression in skin keratinocytes was increased by exposure to UVB light through activation of the AKT pathway. Clinically, we found that SIRT6was upregulated in human skin squamous cell carcinoma. Taken together, our results provide evidence that SIRT6 functions as an oncogene in the epidermis and suggest greater complexity to its role in epithelial carcinogenesis. Cancer Res; 74(20); 5925–33. 2014 AACR.
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Sonia Patel,Monique B. Nilsson,Yan Yang,Xiuning Le,Hai T. Tran,Yasir Y. Elamin,Xiaoxing Yu,Fahao Zhang,Alissa Poteete,Xiaoyang Ren,Ли Шен,Jing Wang,Seyed Javad Moghaddam,Tina Cascone,Michael A. Curran,Don L. Gibbons,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22490453.v1

2023-01-01

Abstract:EGFR-mutant NSCLC tumor cells with acquired resistance to an EGFR-TKI display augmented IL-6 gene expression.
Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419837.v1

2023-01-01

Abstract:Supplementary figure S5. DAC treatment did not increase the risk of osteosarcoma proliferation.
Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1α–Dependent Glycolysis

Guangwei Liu,Yujing Bi,Bo Shen,Hui Yang,Yan Zhang,Xiao Wang,Huanrong Liu,Yun Lu,Jiongbo Liao,Xi Chen,Yiwei Chu

DOI: https://doi.org/10.1158/0008-5472.22401441.v1

2023-01-01

Abstract:PDF file - 436K, Fig.S1. MDSC polarizing differentiation condition alters glycolytic activity. Fig.S2.MDSC SIRT1 expansions in spleen and tumor of SIRT1KO and WT-bearing tumor mice. Fig.S3.SIRT1 deficiency MDSCs showed normal cell death and proliferation. Fig.S4.SIRT1 is required for MDSC polarization. Fig.S5.Characterization of surface marker of bone marrow-derived MDSCs. Fig.S6.SIRT1 intrinsicly controls the function and differentiation of tumor MDSCs. Fig.S7.The potentiating killing activity of SIRT1-/- MDSCs is associated with the higher glycolytic activity. Fig.S8.CD115+ monocytic MDSC effects in tumor killing. Fig.S9.SIRT1 deficiency from MDSCs could not alter the activation of NF-κB signaling after LPS treatment. Fig.S10.SIRT1-dependent MDSC glycolytic activity changes are associated with mTOR-HIF1α pathway. Fig.S11.SIRT-HIF axis directs the function and fate of MDSC associated with glycolytic activity. Fig.S12.SIRT-HIF axis potentiates glycolytic activity and tumor killing ability. Fig.S13.SIRT1 masters MDSC function and fate in tumor through mTOR/HIF1α dependent glycolytic pathway.
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497784.v1

2023-01-01

Abstract:PDF file - 68K, Figure S2: Effect of BMS-777607 on breast cancer cell growth and apoptotic death.
Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507974.v1

2023-01-01

Abstract:Nuclear p53 plays a critical role in synergistic cytotoxic effect in RKO cells.
Supplement Figure 6 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang,Chong Gao,Miao Liu,Yao-Chung Liu,Junsu Kwon,Jun Qi,Xi Tian,Alicia Stein,Yanjing V. Liu,Nikki R. Kong,Yue Wu,Shenyi Yin,Jianzhong Xi,Zhiyuan Chen,Kalpana Kumari,Hannan Wong,Hongbo Luo,Leslie E. Silberstein,Julie A.I. Thoms,Ashwin Unnikrishnan,John E. Pimanda,Daniel G. Tenen,Li Chai

DOI: https://doi.org/10.1158/0008-5472.22430473.v1

2023-01-01

Abstract:Supplement Figure 6
Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Zhengguang Wang,Weiping Li,Xiangling Meng,Benli Jia

DOI: https://doi.org/10.1111/j.1440-1681.2011.05660.x

2011-01-01

Clinical and Experimental Pharmacology and Physiology

Abstract:Summary The currently available chemotherapeutic regimens against gastric cancer are not very effective, leading to high recurrence and poor survival. Resveratrol is a naturally occurring polyphenol with potent apoptosis‐inducing activity. However, the mechanism underlying its actions remains unknown. In the present study, human gastric adenocarcinoma SGC7901 cells were treated with resveratrol (0, 25, 50, 100 and 200 μmol/L) for 48 h, and cellular apoptosis DNA damage were determined. In certain experiments, cells were incubated with superoxide dismutase (100 U/mL), catalase (300 U/mL) or sirtinol (10 μmol/L) to determine the role of reactive oxygen species (ROS) and sirtuin1 in resveratrol‐induced cellular apoptosis. Treatment with resveratrol (50–200 μmol/L) for 48 h significantly induced apoptosis and DNA damage in human gastric cancer SGC7901 cells. This was due to the increased generation of ROS following resveratrol treatment because incubation of cells with superoxide dismutase (100 U/mL) or catalase (300 U/mL) attenuated resveratrol‐induced cellular apoptosis. Interestingly, treatment with resveratrol (25–200 μmol/L) did not affect the level and activity of sirtuin1, whereas the sirtuin1 inhibitor sirtinol (10 μmol/L) significantly reduced sirtuin1 activity. Furthermore, treatment with sirtinol (10 μmol/L) did not have any effect on apoptosis induced by resveratrol. These data provide evidence that resveratrol induces apoptosis via ROS, but independent of sirtuin1, in the human gastric cancer cell line SGC7901.
Supplement Figure 5 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang,Chong Gao,Miao Liu,Yao-Chung Liu,Junsu Kwon,Jun Qi,Xi Tian,Alicia Stein,Yanjing V. Liu,Nikki R. Kong,Yue Wu,Shenyi Yin,Jianzhong Xi,Zhiyuan Chen,Kalpana Kumari,Hannan Wong,Hongbo Luo,Leslie E. Silberstein,Julie A.I. Thoms,Ashwin Unnikrishnan,John E. Pimanda,Daniel G. Tenen,Li Chai

DOI: https://doi.org/10.1158/0008-5472.22430476

2023-01-01

Abstract:Supplement Figure 5
Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma

Sai Chen,Hongxia Chen,Xu Wang,Dongmei Zhang,Li Zhang,Jiawei Cheng,Qi Zhang,Zhixiang Hua,Xu Miao,Jian Shi

DOI: https://doi.org/10.1016/j.abd.2023.08.010

Abstract:Background: Cutaneous squamous cell carcinoma (CSCC) is one of the most common types of skin cancer worldwide. Therefore, the identification of biomarkers associated with CSCC progression could aid in the early detection of high-risk squamous cell carcinoma and the development of novel therapeutic strategies. Objective: This study aimed to investigate the expression patterns of silent mating type Information Regulation 2 homolog 6 (SIRT6) in CSCC and its clinical significance. Methods: The protein expression level of SIRT6 in tissues was detected by immunohistochemistry, and the correlation between SIRT6 expression and clinicopathological parameters in CSCC patients was analyzed. The relative expression of SIRT6 in CSCC cell lineage and tissue specimens was determined by western blotting and PCR. The effect of SIRT6 silencing on cell proliferation was evaluated using cell counting kit 8. Wound healing, transwell method, and flow cytometry were used to investigate the migration, invasion, and cell cycle distribution/apoptosis of CSCC cells after SIRT6 silencing, respectively. Western blot was used to detect the expression of EMT (Epithelial-Mesenchymal Transition), cycle, apoptosis, and other related proteins. Results: The high expression of SIRT6 was correlated with the location of cancer tissue and Broder staging in CSCC patients. Knockdown of SIRT6 inhibited the proliferation, migration, invasion and EMT of CSCC cells, and promoted their apoptosis, with cells blocked in G1 phase. Study limitations: No animal experiments were conducted to further verify the results. Conclusion: Decreased expression of SIRT6 can inhibit the occurrence and development of CSCC.
Supplemental Figure 1 from ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK

Ge Gao,Tianshun Zhang,Qiushi Wang,Kanamata Reddy,Hanyong Chen,Ke Yao,Keke Wang,Eunmiri Roh,Tatyana Zykova,Weiya Ma,Joohyun Ryu,Clara Curiel-Lewandrowski,David Alberts,Sally E. Dickinson,Ann M. Bode,Ying Xing,Zigang Dong

DOI: https://doi.org/10.1158/1535-7163.22507695.v1

2023-01-01

Abstract:ADA-07 synthesis, MS analysis and cytotoxicity assays.
Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Xin Yang,Zhe Wang,Xin Li,Boya Liu,Minghui Liu,Lu Liu,Shuaiyi Chen,Mengmeng Ren,Yankun Wang,Miao Yu,Bo Wang,Junhua Zou,Wei-Guo Zhu,Yuxin Yin,Wei Gu,Jianyuan Luo

DOI: https://doi.org/10.1158/0008-5472.22417766.v1

2023-01-01

Abstract:Figure S1 shows the SIRT5 interaction network and SHMT2 identification. Figure S2 shows that SIRT5 is irreplaceable for cancer cell in response to serine deprivation. Figure S3 shows that SIRT5 desuccinylates SHMT2. Figure S4 shows that SIRT5 upregulates SHMT2 enzymatic activity under metabolic stress. Figure S5 shows that K280 is the major succinylation site of SHMT2. Figure S6 shows that succinylation of SHMT2 at K280 restrains cellular redox balance and clonogenic growth. Figure S7 shows that succinylation of SHMT2 at K280 impairs tumor cell growth in vivo and in vitro
Supplemental Figure 6 from ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK

Ge Gao,Tianshun Zhang,Qiushi Wang,Kanamata Reddy,Hanyong Chen,Ke Yao,Keke Wang,Eunmiri Roh,Tatyana Zykova,Weiya Ma,Joohyun Ryu,Clara Curiel-Lewandrowski,David Alberts,Sally E. Dickinson,Ann M. Bode,Ying Xing,Zigang Dong

DOI: https://doi.org/10.1158/1535-7163.22507680.v1

2023-01-01

Abstract:ADA-07 significantly suppresses SUV-induced skin carcinogenesis in SKH-1 hairless mice (late-stage prevention). A, average body weight of SKH-1 hairless mice. Mice were weighed once a week until week 28. B, external appearance of tumors. SKH-1 hairless mice were treated as described in Materials and Methods. The mice in the control groups (n = 9) received no vehicle/no SUV (n = 3), vehicle/no SUV (n = 3), or 1 mg ADA-07/no SUV (n = 3), respectively. The mice in the rest of the groups received SUV irradiation for 15 weeks 3 times a week. The mice in the vehicle/SUV-treated group (n = 12) were treated with oil-in-water emulsion cream 3 times a week until the end of the experiment (28 weeks). The mice in the 0.1 mg/SUV or 1 mg/SUV groups (n = 12 each) received treatment with ADA-07 (0.1 or 1 mg, respectively) 3 times a week until the end of the experiment (28 weeks). The respective doses of oil-in-water emulsion cream or ADA-07 were applied topically to the dorsal area. Tumor incidence and multiplicity were recorded weekly until the end of the experiment at week 28.
Supplementary Figure 2 from Sunlight UV-Induced Skin Cancer Relies Upon Activation of the P38α Signaling Pathway

Kangdong Liu,Donghoon Yu,Yong-Yeon Cho,Ann M. Bode,Weiya Ma,Ke Yao,Shengqing Li,Jixia Li,G. Tim Bowden,Ziming Dong,Zigang Dong

DOI: https://doi.org/10.1158/0008-5472.22399829

2023-01-01

Abstract:PDF file - 145K, The MAPK protein spectrum activated by UVA, UVB or SUV. (A) N/TERT-1 cells were irradiated with UVA (60 kJ/m2), UVB (3.6 kJ/m2) or SUV (60 kJ UVA/m2/3.6 kJ UVB/m2). Protein extracts (500 μg) were used for MAPK array analysis. Array spots were visualized using an ECL kit. The density of the each duplicated array spot in Fig. 2A was measured as described in Materials and Methods. The graph shows the fold change in SUV-induced phosphorylation of all 21 proteins compared to untreated control (i.e., value of 1). Data are shown as an average of duplicate samples. (B) Identification of proteins comprising the human phospho-MAPK array.
Supplement Figure 4 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang,Chong Gao,Miao Liu,Yao-Chung Liu,Junsu Kwon,Jun Qi,Xi Tian,Alicia Stein,Yanjing V. Liu,Nikki R. Kong,Yue Wu,Shenyi Yin,Jianzhong Xi,Zhiyuan Chen,Kalpana Kumari,Hannan Wong,Hongbo Luo,Leslie E. Silberstein,Julie A.I. Thoms,Ashwin Unnikrishnan,John E. Pimanda,Daniel G. Tenen,Li Chai

DOI: https://doi.org/10.1158/0008-5472.22430479

2023-01-01

Abstract:Supplement Figure 4
UVB Drives Metabolic Rewiring and Epigenetic Reprograming and Protection by Sulforaphane in Human Skin Keratinocytes

Shanyi Li,Hsiao-Chen Dina Kuo,Lujing Wang,Renyi Wu,Davit Sargsyan,Ah-Ng Kong

DOI: https://doi.org/10.1021/acs.chemrestox.1c00432

2022-07-18

Abstract:Sulforaphane (SFN) is a potent anticancer agent which could protect the skin from ultraviolet (UV) radiation-induced insults. Currently, the metabolic rewiring and epigenetic reprograming induced by UVB and the role of SFN in UVB-mediated skin cell transformation remain largely unknown. Herein, we study the metabolome, epigenome, and transcriptome of human keratinocytes (HaCaT cells) exposed to UVB with or without SFN using liquid chromatography-mass spectroscopy, DNA methylation sequencing, and RNA sequencing. UVB increases intracellular reactive oxygen species (ROS) and SFN enhances ROS acutely in post-UVB-exposed HaCaT cells. UVB and SFN alter multiple metabolites and metabolism-related signaling pathways. Pathway analysis shows that UVB impacts numerous signaling pathways including STAT3, inhibition of matrix metalloproteases, and TGF-β, among others. DNA/CpG methylation analysis shows that SFN could partially reverse some of the alterations of UVB-induced CpG methylome. Integrating RNA-seq and Methyl-seq data, starburst plots show the correlation of mRNA expression and CpG methylation status. The potential linkages between the metabolome, CpG methylome, and transcriptome suggest that metabolites produced during metabolism act as cofactors or substrates for catalytic epigenetic modification and transcriptional regulation. These results indicate that UVB drives metabolic rewiring, epigenetic reprograming, and phenotypic transcriptomic alterations and SFN would block or attenuate many of these aberrations, potentially contributing to the overall protective effect of SFN against UVB-induced skin damage.

Supplemental Methods and Figure S1 from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Data from SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Tumor and Stem Cell Biology SIRT 6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplement Figure 6 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Supplement Figure 5 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma

Supplemental Figure 1 from ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK

Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Supplemental Figure 6 from ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK

Supplementary Figure 2 from Sunlight UV-Induced Skin Cancer Relies Upon Activation of the P38α Signaling Pathway

Supplement Figure 4 from Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

UVB Drives Metabolic Rewiring and Epigenetic Reprograming and Protection by Sulforaphane in Human Skin Keratinocytes